3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Primary Myelofibrosis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Psychiatric Rehabilitation
3
Flow Cytometry
3
Watchful Waiting
2
Polymerase Chain Reaction
2
Immunoenzyme Techniques
2
Amplified Fragment Length Polymorphism Analysis
2
ruxolitinib
1
luspatercept
1
Valganciclovir
1
Therapeutics
1
Stem Cell Transplantation
1
Magnetic Resonance Imaging
1
Influenza Vaccines
1
Immunosuppression Therapy
1
Hydroxyurea
1
Ganciclovir
1
Foscarnet
1
Fentanyl
1
Drug Therapy
1
Data Collection
1
Dapsone
1
Antiviral Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Primary Myelofibrosis
×
luspatercept
×
Clear all
NCT01688011
2025-07-03
Connect® Myeloid Disease Registry
Celgene
Terminated
2,013 enrolled